UAB Insight Cancer Volume 2

VOL. 2 NO. 10 CANCER INSIGHT THE At right, the photomicrograph shows the chronic phase of chronic myeloid leukemia. The inset photomicrographs show the leukemia blast cells for a case of acute promyelocytic leukemia. UNIVERSITY OF ALABAMA AT BIRMINGHAM Oncology Advancing at UAB The recruitment of national leaders for UAB programs Publications of Note UAB Medicine News 3 3 a new inpatient consult service, which facilitates is helping keep UAB among the nation’s top cancer screening all new leukemia patients for BMT eligibility treatment and research centers. Boris Pasche, MD, PhD, 2 transplantation. Since arriving at UAB he has established urologic oncology, and thoracic oncology programs New Physicians transplantation, and HLA-mismatch stem cell in bone marrow transplant, hematologic malignancy, and helps in early identification of donors. Over the past director of the Division of Hematology and Oncology, 4 months the numbers of allogeneic BMT procedures provided details: have doubled. Bone Marrow Transplant. Shin Mineishi, MD, PhD, Mineishi leads a staff of six, including Ayman Saad, 3 Noteworthy Presentations 4 MD, previously of the University of Wisconsin. They Vaughan, MD, who has stepped down after a 20-year Featured Clinical Trial recently was recruited as director to succeed William are supported by a 16-bed inpatient BMT unit, an tenure, during which BMT became a premier program. attached 9-bed outpatient BMT unit, and a new Stem Cell Mineishi, formerly of the University of Michigan, is a pioneer in pretransplant conditioning regimens, Laboratory, the only one accredited in Alabama. “BMT is poised for significant growth,” says Pasche. graft versus host disease, complications after stem “We have the infrastructure to expand our applications cell transplantation, reduced intensity stem cell beyond leukemia, lymphoma, and multiple myeloma continued on page 2